How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization? December 7, 2022 Issue Brief This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.
U.S. Global Health Budget Tracker November 14, 2022 Interactive This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels throughout the appropriations process. Data can be customized by fiscal year, sector, and U.S. agency.
The U.S. Government and Global Polio Efforts October 3, 2022 Fact Sheet This fact sheet provides a snapshot of global polio eradication efforts and examines the U.S. government’s role in addressing polio worldwide.
The U.S. Government and Global Health September 26, 2022 Fact Sheet This fact sheet provides an overview of U.S. government global health policy and engagement.
Breaking Down the U.S. Global Health Budget by Program Area September 15, 2022 Fact Sheet The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis; malaria/the President’s Malaria Initiative; the Global Fund to Fight AIDS, Tuberculosis, and Malaria; maternal & child health; nutrition; family planning & reproductive health; global health security; and neglected tropical diseases.
U.S. Global Health Legislation Tracker August 26, 2022 Fact Sheet This tracker provides a listing of global health-related legislation introduced in the current Congress.
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) July 12, 2022 Fact Sheet This fact sheet looks at the history, funding, and future outlook of the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. government’s major global initiative to combat HIV/AIDS.
U.S. Global Funding for COVID-19 by Country and Region: An Analysis of USAID Data June 29, 2022 Issue Brief As Congress again considers increased assistance for the global response to COVID-19, we look at how current U.S. global COVID-19 emergency funding is being channeled, particularly to countries and regions.
The Growth in Share of Medicare Advantage Spending April 7, 2022 Slide Earlier this week, the Biden Administration announced the final Medicare Advantage rates for 2023, which are projected to result in an average increase in Medicare Advantage plan revenue of 8.5% compared to 2022 – the highest average expected increase in recent years. Payments to Medicare Advantage plans as a share…
Domestic HIV Funding in the White House FY 2023 Budget Request March 30, 2022 Issue Brief President Biden released his full FY 2023 budget request on March 28, 2022. The President’s second budget request builds on past efforts to address the domestic HIV response, including by proposing funding increases for the “Ending the HIV Epidemic” (EHE) initiative. The EHE was launched by the Trump Administration in…
